ES8207136A1 - Procedimiento para preparar derivados de guanidina - Google Patents

Procedimiento para preparar derivados de guanidina

Info

Publication number
ES8207136A1
ES8207136A1 ES507570A ES507570A ES8207136A1 ES 8207136 A1 ES8207136 A1 ES 8207136A1 ES 507570 A ES507570 A ES 507570A ES 507570 A ES507570 A ES 507570A ES 8207136 A1 ES8207136 A1 ES 8207136A1
Authority
ES
Spain
Prior art keywords
formula
guanidine derivatives
manufacture
processes
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES507570A
Other languages
English (en)
Other versions
ES507570A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Zeneca Inc
Original Assignee
Imperial Chemical Industries Ltd
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd, ICI Americas Inc filed Critical Imperial Chemical Industries Ltd
Publication of ES8207136A1 publication Critical patent/ES8207136A1/es
Publication of ES507570A0 publication Critical patent/ES507570A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • C07C323/44X or Y being nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/24Derivatives of thiourea containing any of the groups, X being a hetero atom, Y being any atom
    • C07C335/28Y being a hetero atom, e.g. thiobiuret
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE GUANIDINA Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE X ES UNO DE VARIOS TIPOS DE ANILLOS; Y, R1, R2 Y R3 PUEDEN SER VARIOS RADICALES; M VALE 0-4 Y N VALE 1-5. CONSISTE EN LA REACCION E UN COMPUESTO DE FORMULA (II), CON UN RADICAL DE FORMULA R-H, EN LA QUE R ES UN AL COXI O ALQUILTIO C1-6, R24 ES UN RADICAL DESPLAZABLE, A4 PUEDE SER VARIOS TIPOS DE RADICALES Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEV A A CABO EN AGUA, METANOL, ETANOL O PIRIDINA, A LA TEMPERATURA DE EBULLICION DEL DISOLVENTE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO ANTIHISTAMINICOS E INHIBIDORES DE LA SECECION DE ACIDOS GASTRICOS.
ES507570A 1979-11-13 1981-11-30 Procedimiento para preparar derivados de guanidina Granted ES507570A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB7939232 1979-11-13
GB8012789 1980-04-18
GB8026420 1980-08-13

Publications (2)

Publication Number Publication Date
ES8207136A1 true ES8207136A1 (es) 1982-09-01
ES507570A0 ES507570A0 (es) 1982-09-01

Family

ID=27260797

Family Applications (2)

Application Number Title Priority Date Filing Date
ES496810A Granted ES496810A0 (es) 1979-11-13 1980-11-13 Procedimiento para preparar derivados de guanidina.
ES507570A Granted ES507570A0 (es) 1979-11-13 1981-11-30 Procedimiento para preparar derivados de guanidina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES496810A Granted ES496810A0 (es) 1979-11-13 1980-11-13 Procedimiento para preparar derivados de guanidina.

Country Status (15)

Country Link
US (3) US4362728A (es)
EP (1) EP0030092B1 (es)
JP (1) JPH02191247A (es)
AU (1) AU544314B2 (es)
CA (1) CA1136135A (es)
DE (1) DE3070127D1 (es)
DK (1) DK485080A (es)
ES (2) ES496810A0 (es)
FI (1) FI803540L (es)
GR (1) GR71929B (es)
IE (1) IE50440B1 (es)
IL (1) IL61468A0 (es)
NO (1) NO803414L (es)
NZ (1) NZ195568A (es)
PT (1) PT72057B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196923A (en) * 1980-04-29 1983-12-16 Shionogi & Co 2-guanidino-4-(-acylaminoalkyl(thio)methyl)thiazoles and analogs
DE3168031D1 (en) * 1980-07-30 1985-02-14 Ici Plc Guanidine derivatives
WO1982000462A1 (en) * 1980-08-11 1982-02-18 Rech Syntheses Organ Imino-alkyl and amino-nitrile cyano-guanidines
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
US4460584A (en) * 1981-03-13 1984-07-17 Imperial Chemical Industries Plc Nitrogen heterocycles
US4463005A (en) * 1981-03-18 1984-07-31 Imperial Chemical Industries Plc Bicyclic guanidines
IN158869B (es) * 1981-03-18 1987-02-07 Ici Plc
EP0060730A3 (en) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclic derivatives
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4526973A (en) * 1981-05-18 1985-07-02 Bristol-Myers Company Chemical compounds
DE3267110D1 (de) * 1981-05-18 1985-12-05 Ici Plc Amidine derivatives
US4522943A (en) * 1981-05-18 1985-06-11 Bristol-Myers Company Chemical compounds
US4546188A (en) * 1981-05-18 1985-10-08 Bristol-Myers Company Substituted 1,2-diaminocyclobutene-3,4-diones
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
FI832520L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
GR79384B (es) * 1982-08-20 1984-10-22 Hoechst Uk Ltd
US4466970A (en) * 1982-10-02 1984-08-21 Smith Kline & French Laboratories Limited Dioxocyclobutene compounds
JPS5995281A (ja) * 1982-11-19 1984-06-01 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
US4585781A (en) * 1982-12-31 1986-04-29 Glaxo Group Limited Heterocyclic derivatives
DE3334455A1 (de) * 1983-03-04 1984-09-06 Bayer Ag, 5090 Leverkusen Guanidin - derivate
JPS59167570A (ja) * 1983-03-04 1984-09-21 バイエル・アクチエンゲゼルシヤフト グアニジン誘導体
ES521588A0 (es) * 1983-03-30 1984-08-16 Ferrer Int Procedimiento de obtencion de nuevas n-ciano-formamidinas.
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors
US4985459A (en) * 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4906625A (en) * 1984-02-08 1990-03-06 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4683243A (en) * 1984-02-08 1987-07-28 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4755532A (en) * 1984-02-08 1988-07-05 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
KR890014504A (ko) * 1988-03-11 1989-10-24 우대규 4-(2'-시아노 에틸티오)메틸-2-구아니디노티아졸의 제조방법
AU618355B2 (en) * 1988-05-19 1991-12-19 Hu-Metal Engineering Pty. Ltd. Improvements relating to plate bending
US5028716A (en) * 1989-01-30 1991-07-02 Taisho Pharmaceutical Co., Ltd. 3,5-diamino-1,2,4-triazole derivatives
FR2647112A1 (fr) * 1989-05-22 1990-11-23 Atochem Composes polyfluoralkyle azotes, leurs procedes de preparation et leurs applications
WO1994021621A1 (en) * 1993-03-23 1994-09-29 Astra Aktiebolag Guanidine derivatives useful in therapy
US6066740A (en) * 1997-11-25 2000-05-23 The Procter & Gamble Company Process for making 2-amino-2-imidazoline, guanidine and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
EP2725021A1 (de) 2008-06-13 2014-04-30 Bayer CropScience AG Neue heteroaromatische Thioamide als Schädlingsbekämpfungsmittel
EP2161259A1 (de) 2008-09-03 2010-03-10 Bayer CropScience AG 4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer
USD1035780S1 (en) * 2021-01-29 2024-07-16 Fuzhou Leisiao Information Technology Co., Ltd. Electric scooter

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
IE47044B1 (en) * 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
GB2001624B (en) * 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
EP0006679B1 (en) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4374836A (en) * 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
EP0010893B1 (en) * 1978-10-16 1984-02-08 Imperial Chemical Industries Plc Antisecretory branched-chain heterocyclic guanidine derivatives, processes for their manufacture, intermediates, and pharmaceutical compositions containing said derivatives
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them
US4239908A (en) * 1979-12-10 1980-12-16 G.D. Searle & Co. N-aralkenyl-N'-cyano-N"-(heterocyclylthioalkyl)-guanidines
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
US4336255A (en) * 1981-03-24 1982-06-22 Smithkline Corporation Pharmaceutical compositions containing guanidinopyrimidines
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規2−グアニジノチアゾリン誘導体ならびにその製造法

Also Published As

Publication number Publication date
US4604465A (en) 1986-08-05
ES8203076A1 (es) 1982-03-01
DK485080A (da) 1981-05-14
EP0030092A1 (en) 1981-06-10
IL61468A0 (en) 1980-12-31
IE50440B1 (en) 1986-04-16
ES496810A0 (es) 1982-03-01
AU544314B2 (en) 1985-05-23
JPH02191247A (ja) 1990-07-27
GR71929B (es) 1983-08-19
US4762932A (en) 1988-08-09
AU6438480A (en) 1981-09-17
EP0030092B1 (en) 1985-02-06
NZ195568A (en) 1983-04-12
ES507570A0 (es) 1982-09-01
CA1136135A (en) 1982-11-23
IE802359L (en) 1981-05-13
US4362728A (en) 1982-12-07
PT72057B (en) 1981-09-24
NO803414L (no) 1981-05-14
DE3070127D1 (en) 1985-03-21
FI803540L (fi) 1981-05-14
JPH0262547B2 (es) 1990-12-26
PT72057A (en) 1980-12-01

Similar Documents

Publication Publication Date Title
ES8207136A1 (es) Procedimiento para preparar derivados de guanidina
ES8607969A1 (es) Un procedimiento para preparar un derivado de acido quinoli-no naftiridin- carboxilico
ES8304097A1 (es) Un procedimiento para la obtencion de un compuesto de 4(3h- quinazolinona).
SE7712630L (sv) Forfarande for framstellning av o-alkylerade hydroxylaminer
ES8307774A1 (es) Un procedimiento para la preparacion de nuevos derivados de diaminosotiazol.
ES8802039A1 (es) Procedimiento par preparar derivados de 1-piperazinacarboxamida
ES8105690A1 (es) Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
US4297357A (en) N-Phenethylacetamide compounds and process for preparation thereof
ES421067A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
ES423232A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino-i-midazolinas-(2) sustituidas.
ES417700A1 (es) Procedimiento para la preparacion de benceno-1,3-disulfona-midas sustituidas con radicales basicos.
ES378204A1 (es) Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles sustituidos en el grupo amino.
ES386847A1 (es) Procedimiento para la preparacion de derivados de acidos alfa-aminooxicarboxilicos.
ES479532A1 (es) Procedimiento de preparacion de enaminas de aminoacidos y sus silil-derivados.
ES419548A1 (es) Procedimiento para la preparacion de indazoles sustituidos.
ES389882A1 (es) Procedimiento para la preparacion de 7-acil-1,2,4,5 - te- trahidro - (3h) - benzazepinas.
KR820001615B1 (ko) N-펜에틸 아세트아미드 화합물의 제조방법
ES8300115A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES428457A1 (es) Procedimiento de preparacion de derivados de salicilamidas.
ES8206460A1 (es) Procedimiento para preparar formamidinas 3,3-disustituidas
ES433901A1 (es) Procedimiento para la preparacion de nuevas bencilaminas.
ES422737A1 (es) Procedimiento para la obtencion de compuestos heterocicli- cos a base de piperazina u homopiperazina.
ES8702394A1 (es) Procedimiento para preparar nuevos derivados de acido sulfa-moilbenzoico
ES433892A1 (es) Procedimiento para la preparacion de nuevas bencilaminas.
ES8205193A1 (es) Procedimiento para la obtencion de sales de acidos alcancar-boxilicos